A PROSPECTIVE RANDOMIZED TRIAL OF 5-FLUOROURACIL VERSUS 5-FLUOROURACIL AND HIGH-DOSE LEUCOVORIN VERSUS 5-FLUOROURACIL AND METHOTREXATE IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA

被引:456
|
作者
PETRELLI, N
HERRERA, L
RUSTUM, Y
BURKE, P
CREAVEN, P
STULC, J
EMRICH, LJ
MITTELMAN, A
机构
[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT CLIN PHARMACOL,BUFFALO,NY 14263
[2] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT THERAPEUT,BUFFALO,NY 14263
[3] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT EXPTL THERAPEUT,BUFFALO,NY 14263
[4] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT BIOMATH,BUFFALO,NY 14263
关键词
D O I
10.1200/JCO.1987.5.10.1559
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1559 / 1565
页数:7
相关论文
共 50 条
  • [21] SEQUENTIAL COMBINATION CHEMOTHERAPY WITH METHOTREXATE AND 5-FLUOROURACIL IN ADVANCED COLORECTAL-CARCINOMA
    RABINOVICH, MG
    PEREZ, JE
    MACCHIAVELLI, M
    ROMERO, A
    KREMER, A
    LEONE, BA
    STRAUSS, E
    TUMORI JOURNAL, 1984, 70 (06): : 549 - 553
  • [22] SEQUENTIAL THERAPY WITH METHOTREXATE AND 5-FLUOROURACIL IN THE TREATMENT OF ADVANCED COLORECTAL-CARCINOMA
    LEONE, BA
    ROMERO, A
    RABINOVICH, MG
    PEREZ, JE
    MACCHIAVELLI, M
    STRAUSS, E
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (01) : 23 - 27
  • [23] A COMBINATION OF 5-FLUOROURACIL AND THYMIDINE IN ADVANCED COLORECTAL-CARCINOMA
    STERNBERG, A
    PETRELLI, NJ
    AU, J
    RUSTUM, Y
    MITTELMAN, A
    CREAVEN, P
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 13 (03) : 218 - 222
  • [24] Prospective randomized trial of 5-fluorouracil versus 5-fluorouracil plus levamisole in the treatment of metastatic colorectal cancer: A Hoosier Oncology Group trial
    Bandealy, MT
    Gonin, R
    Loehrer, PJ
    Monaco, F
    Einhorn, LH
    CLINICAL CANCER RESEARCH, 1998, 4 (04) : 935 - 939
  • [25] 5-fluorouracil versus folinic acid and 5-fluorouracil in advanced, hormone-resistant prostate cancer: A prospective, randomized pilot trial
    Breul, J
    Jakse, G
    Forster, G
    Lampel, A
    Rohani, A
    Hartung, R
    EUROPEAN UROLOGY, 1997, 32 (03) : 280 - 283
  • [26] PROSPECTIVE MULTICENTER PHASE-III TRIAL OF DOXIFLURIDINE (5'DFUR) VERSUS 5-FLUOROURACIL IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA
    SCHUSTER, D
    HEIM, ME
    DOMBERNOWSKI, P
    WOOD, C
    QUEISSER, W
    ONKOLOGIE, 1991, 14 (04): : 333 - 337
  • [27] Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma
    Hainsworth, JD
    Jolivet, J
    Birch, R
    Hopkins, LG
    Greco, FA
    CANCER, 1997, 79 (04) : 740 - 748
  • [28] Adjuvant chemotherapy in stage III colon cancer with 5-fluorouracil and levamisole versus 5-fluorouracil and leucovorin
    Dencausse, Y
    Hartung, G
    Sturm, J
    Kopp-Schneider, A
    Hagmüller, E
    Wojatschek, C
    Lindemann, H
    Fritze, D
    Queisser, W
    ONKOLOGIE, 2002, 25 (05): : 426 - 430
  • [29] SEQUENTIAL METHOTREXATE, 5-FLUOROURACIL (5-FU), AND HIGH-DOSE LEUCOVORIN VERSUS 5-FU AND HIGH-DOSE LEUCOVORIN VERSUS 5-FU ALONE FOR ADVANCED COLORECTAL-CANCER - A MULTIINSTITUTIONAL RANDOMIZED TRIAL
    ABAD, A
    GARCIA, P
    GRAVALOS, C
    TUSQUETS, I
    FONT, A
    PEREZ, G
    CORTESFUNES, H
    FABREGAT, X
    BARNADAS, A
    ROSELL, R
    CANCER, 1995, 75 (06) : 1238 - 1244
  • [30] A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer
    Chang, HM
    Jung, KH
    Kim, TY
    Kim, WS
    Yang, HK
    Lee, KU
    Choe, KJ
    Heo, DS
    Bang, YJ
    Kim, NK
    ANNALS OF ONCOLOGY, 2002, 13 (11) : 1779 - 1785